Abstract
We present a precision medicine application developed for multiple sclerosis (MS): the MS BioScreen. This new tool addresses the challenges of dynamic management of a complex chronic disease; the interaction of clinicians and patients with such a tool illustrates the extent to which translational digital medicine - that is, the application of information technology to medicine - has the potential to radically transform medical practice. We introduce 3 key evolutionary phases in displaying data to health care providers, patients, and researchers: visualization (accessing data), contextualization (understanding the data), and actionable interpretation (real-time use of the data to assist decision making). Together, these form the stepping stones that are expected to accelerate standardization of data across platforms, promote evidence-based medicine, support shared decision making, and ultimately lead to improved outcomes.
Original language | English (US) |
---|---|
Pages (from-to) | 633-642 |
Number of pages | 10 |
Journal | Annals of neurology |
Volume | 76 |
Issue number | 5 |
DOIs | |
State | Published - Nov 1 2014 |
ASJC Scopus subject areas
- Clinical Neurology
- Neurology